Advertisement
Advertisement
SUPN
Supernus Pharmaceuticals, Inc.
43.83
USDSponsored
+0.08
+0.18%
Sep 23, 11:28 UTC -4
Open
SUPN Earnings Reports
Positive Surprise Ratio
SUPN beat 32 of 43 last estimates.
74%
Next Report
Date of Next Report
Nov 02, 2026
Estimate for Q3 26 (Revenue/ EPS)
$224.63M
/$0.62
Implied change from Q2 26 (Revenue/ EPS)
+2.54%
/+16.98%
Implied change from Q3 25 (Revenue/ EPS)
+16.93%
/-38.61%
Supernus Pharmaceuticals, Inc. earnings per share and revenue
On Aug 03, 2026, SUPN reported earnings of 0.53 USD per share (EPS) for Q2 26, beating the estimate of 0.42 USD, resulting in a 23.72% surprise. Revenue reached 219.06 million, compared to an expected 209.06 million, with a 4.78% difference. The market reacted with a +8.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.62 USD, with revenue projected to reach 224.63 million USD, implying an increase of 16.98% EPS, and increase of 2.54% in Revenue from the last quarter.
FAQ
What were Supernus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Supernus Pharmaceuticals, Inc. reported EPS of $0.53, beating estimates by 23.72%, and revenue of $219.06M, 4.78% above expectations.
How did the market react to Supernus Pharmaceuticals, Inc.'s Q2 2026 earnings?
The stock price moved up 8.46%, changed from $43.25 before the earnings release to $46.91 the day after.
When is Supernus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for Nov 02, 2026.
What are the forecasts for Supernus Pharmaceuticals, Inc.'s next earnings report?
Based on 6
analysts, Supernus Pharmaceuticals, Inc. is expected to report EPS of $0.62 and revenue of $224.63M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.